-
Eli Lilly Makes An $8B Cancer Genetics Bet With Loxo Acquisition
Jan 7, 2019, 10:09 AM by Michael CroftXconomy | Eli Lilly is set to acquire Loxo Oncology for approximately $8 billion---a deal that brings to the Indianapolis pharmaceutical giant a class of drugs that treat cancers with particular genetic signatures.Full story -
10x Genomics Announces $35m Funding
Jan 7, 2019, 08:05 AM by Michael CroftFull storyBio-IT World News Brief | On day one of the JP Morgan Healthcare Conference, 10x Genomics announces $35 million in funding as an extension of its Series D financing.
-
Creative Proteomics Upgrades Four Proteomics Services for Protein Related Projects
Jan 3, 2019, 22:55 PM by Michael CroftSHIRLEY, NY - Jan 5, 2019 - Creative Proteomics, a leading supplier in drug development services, recently announces that they have upgraded four services related to protein research projectsFull story -
Bristol-Myers Squibb Will Acquire Celgene In Blockbuster $74B Deal
Jan 3, 2019, 09:44 AM by Michael CroftSTAT | The transaction between biopharma giants joins two of the largest companies in oncology, both of which have been facing setbacks.Full story -
Top 10 Stories Of 2018: Data Science, Five Use Cases For AI And Machine Learning, And More
Jan 2, 2019, 11:45 AM by Michael CroftFull storyBio-IT World | As we head into 2019, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2018.
-
Poll Americans Support Gene-Editing Embryos To Prevent Diseases
Dec 28, 2018, 12:53 PM by Michael CroftSTAT | Most Americans say it would be OK to use gene-editing technology to create babies protected against a variety of diseases - but a new poll shows they'd draw the line at changing DNA so children are born smarter, faster or taller.Full story -
AI In The Clinic: What AI Will Look Like For Healthcare
Dec 21, 2018, 13:00 PM by Michael CroftBio-IT World | Artificial Intelligence will have as transformational an impact as the internet did, predicts Jay Bellissimo, managing partner at IBM services. Every company needs an AI strategy, he says, and it is not a problem only for IT. Data creates insight, and insight creates knowledge. Mining the 80% of the data that’s not searchable via the internet is your company’s data advantage.Full story -
PetaGene Announces $2.1M To Further Genomic Compression
Dec 20, 2018, 10:05 AM by Michael CroftBio-IT World News Brief PetaGene, a two-time winner of Bio-IT World’s Best of Show award for product excellence, has announced $2.1 million in new funding.Full story -
Biogen, DDN, Qlucore, And More: News From December 2018
Dec 19, 2018, 10:00 AM by Michael CroftBio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Biogen, DDN, Qlucore, and more.Full story -
Certara Publishes New Report Investigating Success Factors for Outcomes-based Contracting, Giving Guidelines to Pharma and Payers
Dec 19, 2018, 08:14 AM by Michael CroftPRINCETON, NJ - Dec 19, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced a new research report that investigates the potential of pharmaceutical outcomes-based contractingFull story -
CD Genomics Claims a Discount for Most Services to Celebrate Christmas&New Year
Dec 18, 2018, 22:59 PM by Michael CroftSHIRLEY, NY - Dec 19, 2018 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the launch of Christmas and New Year promotion from December 1st to January 31stFull story -
Vyasa Analytics Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research
Dec 18, 2018, 15:43 PM by Michael CroftBOSTON, MA - Dec 18, 2018 - Vyasa Analytics, a provider of scalable, deep-learning software and analytics for life sciences and healthcare organizations, today announced they have joined Accentures partner ecosystem, designed to help independent software vendors (ISVs) and life science companies work more effectively to accelerate drug discovery efforts and improve patient outcomesFull story -
Creative Biolabs Announced the Monoclonal Antibody Screening Technology for Research Use
Dec 18, 2018, 00:33 AM by Michael CroftSHIRLEY, NY - Dec 18, 2018 - December 18, 2018, Creative Biolabs, one of world-leading suppliers and manufacturers from USA, announced a technique about the monoclonal antibody screening for research useFull story -
Oak Ridge Tackles Opioids With Assistance From World’s Fastest Supercomputer
Dec 14, 2018, 08:05 AM by Michael CroftFull storyBio-IT World | The US Department of Energy’s Oak Ridge National Laboratory is tackling the opioid crisis by using the world’s fastest supercomputer. With the help of IBM’s recently launched Summit supercomputer, the Oak Ridge team was able to analyze 85 million genetic markers and understand complex, epistatic genetic architectures responsible for challenging traits in phenotype.
-
Allen Institute Announces New Division Dedicated To Studying Human Immune System
Dec 13, 2018, 10:20 AM by Michael CroftFull storyBio-IT World | The Allen Institute announced a new division, the Allen Institute for Immunology, which will be dedicated to studying the human immune system.
-
Linguamatics Highlights 2018 Achievements and Advances NLP Text Analytics Market Leadership
Dec 12, 2018, 11:49 AM by Michael CroftCAMBRIDGE, N/A, UNITED KINGDOM - Dec 12, 2018 - In 2018, Linguamatics advanced its position as the market-leading provider of natural language processing (NLP) text analytics for healthcare and the life sciences, winning prestigious industry awards, introducing innovative product enhancements, and partnering with organizations to extend the value of Linguamatics solutionsFull story -
Pharma’s AI Future
Dec 12, 2018, 09:55 AM by Michael CroftFull storyBio-IT World | The recent AI World Conference & Expo made one thing clear: now is the time for pharma to embrace AI and start realizing some of the benefits other industries are enjoying.
-
OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD
Dec 12, 2018, 07:44 AM by Michael CroftSTOCKHOLM, SWEDEN - Dec 12, 2018 - Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US marketFull story -
Creative Diagnostics Introduces Cytotoxic Drug Antibodies for Science Community
Dec 12, 2018, 01:33 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Dec 13, 2018 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics is proud to announce that it has launched a new set of antibodies specific to cytotoxic drugs for life science community facing the growing challenges for scientific researchFull story -
Rho Announces New Regulatory Strategy and Submissions Business Segment
Dec 11, 2018, 09:53 AM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Dec 10, 2018 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced a new Regulatory Strategy and Submissions business segmentFull story